DHR vs TMO: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
TMO |
| Current Price |
$174.04 |
$462.60 |
| Fair Value Estimate |
$197.01 |
$509.20 |
| Upside to Fair Value |
+13.2%
|
+10.1%
|
| Market Cap |
$123.2B |
$171.9B |
| Forward P/E |
33.4x
|
25.1x
|
| EV / EBITDA |
20.3x
|
19.0x
|
| Price / Sales |
5.0x
|
3.8x
|
| Price / FCF |
23.3x
|
25.5x
|
| Revenue Growth YoY |
+3.7%
|
+6.2%
|
| Gross Margin |
60.7%
|
39.4%
|
| Operating Margin |
21.0%
|
17.8%
|
| Return on Equity |
7.1%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
3.92%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
DHR |
TMO |
| Zone Low |
$147.76 |
$381.90 |
| Zone High |
$167.46 |
$432.82 |
| In Buy Zone? |
No
|
No
|